MedTrace Logo

Investigation of a Novel Oropharyngeal Airway: The ManMaxAirway

NCT03969147 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-05-31

No results posted yet for this study

Summary

Guedel pattern or oropharyngeal airways (OPA) maintain an open oral airway in unconscious or semi-conscious patients by preventing the tongue from covering the epiglottis, but OPA placement carries a risk of inducing gag reflex and vomiting. Although various sizes are available, the design of the OPA has undergone little change since its introduction in the 1920s. The purpose of this study is to determine the utility of a novel airway device, the ManMaxAirway (MMA), as an alternative to the OPA.

Conditions

  • Airway Obstruction
  • Respiratory Complication

Interventions

DEVICE

ManMaxAirway oropharyngeal airway adjunct

Healthy volunteers will self-place the ManMaxAirway.

DEVICE

Guedel Oropharyngeal airway adjunct

Healthy volunteers will self-place the standard Guedel OPA.

DEVICE

No airway adjunct

Healthy volunteers will have no airway adjunct in place.

Sponsors & Collaborators

  • University of Vermont

    lead OTHER

Principal Investigators

  • Kalev Freeman, MD, PhD · University of Vermont Department of Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03969147 on ClinicalTrials.gov